The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice

Immunology

Volumn 133, Issue 1, 2011, Pages 133-140

  Zhou, Yixuan ^a   Yuan, Jingdong ^b   Zhou, Bin ^a   Lee, Austin J ^a   Lee, Albert J ^a   Ghawji Jr, Maher ^a   Yoo, Tai June ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b First Hospital of Wuhan   (China)

Author keywords

Autoimmunity; Cytokines; Stem cells; Therapy immunotherapy

Indexed keywords

AUTOANTIGEN; BETA TUBULIN; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUDITORY CORTEX; AUDITORY THRESHOLD; BRAIN STEM; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE HEARING LOSS; EXPERIMENTAL STUDY; FEMALE; HAIR CELL; HEARING LOSS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; THERAPY EFFECT; TREATMENT DURATION;

ADIPOSE TISSUE; ANIMALS; AUTOIMMUNE DISEASES; CELL SEPARATION; EVOKED POTENTIALS, AUDITORY; FEMALE; FLOW CYTOMETRY; HEARING LOSS, BILATERAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; TH1 CELLS; TH17 CELLS;

EID: 79953315577     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03421.x     Document Type: Article

References (33)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88:585-9.
2. Buniel MC, Geelan-Hansen K, Weber PC, Tuohy VK. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 2009; 1:425-34.
3. Baek MJ, Park HM, Johnson JM et al. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol 2009; 6:4203-10.
4. Billings PB, Keithley EM, Harris JP. Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol 1995; 104:181-8.
5. Billings PB, Shin SO, Harris JP. Assessing the role of anti-hsp70 in cochlear impairment. Hear Res 1998; 126:210-3.
6. Yoo TJ, Tomoda K, Stuart JM, Cremer TA, Townes AS, Kang AH. Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol 1983; 92:267-71.
7. Yoo TJ, Yazawa Y, Tomoda K, Floyd R. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science 1983; 222:65-7.
8. + T cells specific for inner ear peptides. J Clin Invest 2004; 113:1210-7.
9. Yoo TJ, Shea J Jr, Ge X et al. Presence of autoantibodies in the sera of Ménière's disease. Ann Otol Rhinol Laryngol 2001; 110:425-9.
10. Zhou B, Kermany MH, Glickstein J, et al. Murine autoimmune hearing loss mediated by CD4(+) T cells specific for β-tubulin. Clin Immunol 2011; 138:222-30.
11. Yoo TJ, Du X, Kwon SS. Molecular mechanism of autoimmune hearing loss. Acta Otolaryngol Suppl 2002; 548:3-9.
12. Du X, Yoo TJ, Mora R. Distribution of beta-tubulin in guinea pig inner ear ORL. J Otorhinolaryngol Relat Spec 2003; 65:7-16.
13. Cai Q, Du X, Zhou B, Cai C, Kermany MH, Yoo T. Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease. ORL J Otorhinolaryngol Relat Spec 2009; 71:135-41.
14. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7.
15. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 2009; 106:984-91.
16. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009; 60:1006-19.
17. Nasef A, Ashammakhi N, Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen Med 2008; 3:531-46.
18. Noël D, Djouad F, Bouffi C, Mrugala D, Jorgensen C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 2007; 48:1283-9.
19. Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 2009; 5:392-9.
20. Glennie S, Soeiro I, Dyson PJ, Lam W, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105:2821-7.
21. Wehner R, Wehrum D, Bornhäuser M et al. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica 2009; 94:1151-6.
22. Bouffi C, Djouad F, Mathieu M, Noël D, Jorgensen C. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology (Oxford) 2009; 48:1185-9.
23. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56:1175-86.
24. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24:2582-91.
25. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105:2214-9.
26. Puissant B, Barreau C, Bourin P et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129:118-29.
27. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA. The development and function of regulatory T cells. Cell Mol Life Sci 2009; 66:2603-22.
28. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87.
29. + regulatory T cells. Arthritis Rheum 2005; 52:2212-21.
30. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007; 56:732-42.
31. Battaglia M, Gianfrani C, Gregori S, Roncarolo MG. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci 2004; 1029:142-53.
32. Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002; 129:263-76.
33. Lloyd CM, Hawrylowicz CM. Regulatory T cells in asthma. Immunity 2009; 31:438-49.